You just read:

Foamix Announces FDA Acceptance of its New Drug Application for FMX103 Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea

News provided by

Foamix Pharmaceuticals Ltd.

Oct 17, 2019, 11:21 ET